FIELD: medicine, pharmacy.
SUBSTANCE: invention proposes a pharmaceutical composition comprising the following components, %: hydrophobic active component representing cyclosporine and/or taxane, 0.1-60.0; one or some gelatinizing substances chosen from fatty acid polyglycerol esters, 0.1-60.0; one or some gel-forming substances chosen from oleic acid polyglycerol-3-esters, 1.0-60.0; one or some substances chosen from triglyceride macrogol glycerol esters, partial glycerides or fatty acids, or fatty acid macrogol esters. In dilution with water the composition forms dispersion of polymorphous nonspherical gel particles of size from 0.2 to 500 mcm. Invention provides acceptable availability of therapeutically active cyclosporines and taxanes showing difficult water solubility.
EFFECT: improved and valuable properties of composition.
14 cl, 1 tbl, 8 dwg, 20 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS FOR ORAL AND TOPICAL USING | 2003 |
|
RU2279895C2 |
| PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2639482C2 |
| PHARMACEUTICAL COMPOSITION FOR SOLUBILIZATION OF POORLY SOLUBLE ACTIVE AGENT IN COMPOSITION-CARRIER AND METHOD OF ITS MAKING | 1994 |
|
RU2140291C1 |
| PRELIMINARY PREPARED EMULSION CONCENTRATES CONTAINING CYCLOSPORINE OR MACROLIDE | 1999 |
|
RU2235554C2 |
| ANTIFUNGAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING ITRACONAZOLE AND METHOD FOR ITS PREPARING | 2000 |
|
RU2216323C2 |
| PHARMACEUTICAL COMPOSITION DESIGNATED FOR ORAL ADMINISTRATION OF PYRAZOLE-3-CARBOXAMIDE DERIVATIVE | 2004 |
|
RU2321404C1 |
| COSMETIC OR DERMATOLOGICAL COMPOSITION CONTAINING COMPOUND HAVING HYDROGEN-LINKING ABILITY, AND METHOD OF COSMETIC TREATMENT | 2009 |
|
RU2432151C2 |
| SEMIFIRM SYSTEMS CONTAINING DERIVATIVES OF AZETIDINUM | 2004 |
|
RU2343915C2 |
| USE OF POLYGLYCEROL ESTERS AS TRIBO-MODIFIERS IN LUBRICATING COMPOSITIONS | 2016 |
|
RU2726194C2 |
| PEROXIDE DISPERSIONS | 2013 |
|
RU2631815C2 |
